Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (Q83767469)

1

object named as

Chaolin Huang

0 references

Yeming Wang

2

object named as

Yeming Wang

0 references

author name string

Xingwang Li

3

0 references

Lili Ren

4

0 references

Jianping Zhao

5

0 references

Li Zhang

7

0 references

Guohui Fan

8

0 references

Jiuyang Xu

9

0 references

Xiaoying Gu

10

0 references

Zhenshun Cheng

11

0 references

Ting Yu

12

0 references

Jiaan Xia

13

0 references

Yuan Wei

14

0 references

Wenjuan Wu

15

0 references

Xuelei Xie

16

0 references

Wen Yin

17

0 references

Hui Li

18

0 references

Min Liu

19

0 references

Yan Xiao

20

0 references

Hong Gao

21

0 references

Li Guo

22

0 references

Jungang Xie

23

0 references

Guangfa Wang

24

0 references

Rongmeng Jiang

25

0 references

Zhancheng Gao

26

0 references

Qi Jin

27

0 references

Jianwei Wang

28

0 references

Bin Cao

29

0 references

language of work or name

English

0 references

publication date

24 January 2020

1 reference

https://www.ncbi.nlm.nih.gov/pubmed/31986264

full work available at URL

3 March 2020

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159299/

0 references

published in

The Lancet

0 references

volume

395

0 references

page(s)

497-506

0 references

issue

10223

0 references

on focus list of Wikimedia project

0 references

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Coronaviruses post-SARS: update on replication and pathogenesis

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

A major outbreak of severe acute respiratory syndrome in Hong Kong

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile.

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

SARS: systematic review of treatment effects

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Origin and evolution of pathogenic coronaviruses

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting

25 February 2021

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(20)30183-5

CDC definitions for nosocomial infections, 1988

25 February 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2820%2930183-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Corticosteroids as adjunctive therapy in the treatment of influenza

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31986264

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0140-6736(20)30183-5

0 references

COVIDWHO ID

covidwho-34

0 references

Dimensions Publication ID

1124290823

1 reference